| | | | | | | |
 | GILEAD SCIENCES, INC. | 1.03% | 2.83% | -10.47% | -1.84% | -2.81% | 81 543 |
| REGENERON PHARMACEUTICALS, INC. | 0.71% | 4.81% | 9.40% | 38.72% | 121.04% | 74 440 |
| VERTEX PHARMACEUTICALS | 0.88% | 7.33% | 23.33% | 29.74% | 57.68% | 69 269 |
 | WUXI APPTEC CO., LTD. | -1.00% | -4.78% | -22.98% | -35.15% | 169.49% | 39 423 |
| BIONTECH SE | 0.11% | -1.52% | -40.00% | -21.69% | --.--% | 37 588 |
 | GENMAB A/S | -0.61% | -0.71% | -19.73% | -13.23% | 72.54% | 19 850 |
 | ARGENX SE | 0.61% | 0.31% | -6.25% | 31.55% | 144.70% | 17 140 |
| BEIGENE, LTD. | 3.59% | -2.81% | -52.97% | -63.63% | 0.63% | 13 146 |
| NEUROCRINE BIOSCIENCES, INC. | 4.47% | 4.04% | 3.77% | -8.50% | 10.63% | 8 447 |
| HALOZYME THERAPEUTICS, INC. | 3.28% | 0.81% | 15.12% | 9.61% | 200.39% | 6 378 |
| LEGEND BIOTECH CORPORATION | 0.33% | -3.74% | -15.98% | 7.08% | --.--% | 6 040 |
| SAREPTA THERAPEUTICS, INC. | -0.51% | 0.03% | -23.94% | -8.80% | -43.32% | 5 993 |
| EXELIXIS, INC. | 0.62% | -8.62% | -2.57% | -20.35% | -12.52% | 5 712 |
| INTRA-CELLULAR THERAPIES, INC. | -0.51% | -3.13% | 8.27% | 47.89% | 320.71% | 5 345 |
| ASCENDIS PHARMA A/S | -0.22% | 5.00% | -32.88% | -31.90% | -29.98% | 5 039 |
| | | | | | | |
| | Durchschnitt | 0.85% | -0.01% | -11.19% | -2.70% | 77.63% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 0.67% | 1.98% | -6.05% | 5.04% | 73.88% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
